Insight into the Functional and Structural Properties of 3-Arylcoumarin as an Interesting Scaffold in Monoamine Oxidase B Inhibition (Q57412727)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Insight into the functional and structural properties of 3-arylcoumarin as an interesting scaffold in monoamine oxidase B inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

0 references

Nicholas P. Tatonetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Eugenio Uriarte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Lourdes Santana

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Dolores Viña

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Santiago Vilar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Verónica García-Morales

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Maria João Matos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

8 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

1488-1500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

Multi-target-directed ligands to combat neurodegenerative diseases

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Musculoskeletal problems as an initial manifestation of Parkinson's disease: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

MAO-inhibitors in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FCMDC.201300533

21 January 2018

https://api.crossref.org/works/10.1002%2FCMDC.201300533

7 January 2021

Drosophila as a model for human neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

MAO inhibitors: risks, benefits, and lore

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Enzymology of monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Monamine oxidase inhibitors: current and emerging agents for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Monoamine oxidase-B inhibition in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Oxidative stress and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Discovery of MAO-B inhibitors - present status and future directions part I: oxygen heterocycles and analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Structural and Mechanistic Studies of Mofegiline Inhibition of Recombinant Human Monoamine Oxidase B ∥

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Clinical pharmacology of MAO inhibitors: safety and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Structure of human monoamine oxidase A at 2.2-A resolution: The control of opening the entry for substrates/inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

The molecular pharmacology of L-deprenyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

On the partition of ampholytes: application to blood-brain distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Correlation of blood-brain penetration using structural descriptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

Arguments for the use of dopamine receptor agonists in clinical and preclinical Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

7 January 2021

Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

7 January 2021

3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

7 January 2021

Hydroxycoumarins as selective MAO-B inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300533

7 January 2021

Identifiers

DOI

10.1002/CMDC.201300533

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715707%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference